GROOVE BOTANICALS INC.
GROOVE BOTANICALS INC.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents At Carrying Value | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Receivable Net Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Interest Payable Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Convertible Notes Payable Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Dividends Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | |||||
Retained Earnings Accumulated Deficit | -36 | -36 | -35 | -35 | -35 | -35 | -35 | -35 | -35 | -35 | -35 | -35 | |||||
Stockholders Equity | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | |||||
Common Stock Shares Issued | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 59 | |||||
Shares Outstanding | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 59 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2026 | 0.00% | 49.06% | 28.30% | -2.30% | 160.92% | 19.54% | -5.77% | -11.54% | -10.58% | 0.00% | - | - |
| 2025 | -19.35% | -56.45% | -56.45% | -77.78% | 201.85% | 31.48% | 0.00% | -53.33% | -16.67% | 35.29% | 3.92% | 3.92% |
| 2024 | - | - | - | 0.00% | 28.57% | 42.86% | 12.50% | 25.00% | -23.50% | -19.35% | -19.35% | -56.45% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | |||||
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Working Capital | -1.54M | -1.47M | -1.38M | -1.29M | -1.20M | -1.11M | -1.02M | -936.16K | -851.71K | -760.56K | -649.48K | -639.07K | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.00 | -1.00 | -1.00 | -1.01 | -1.00 | -1.00 | -1.00 | -1.01 | -1.00 | -1.00 | -1.01 | -1.03 | |||||
| Interest Coverage TTM | - | - | - | - | - | - | - | - | - | -97.56 | -21.99 | -11.06 | |||||
| Debt Ratio | 612.50 | 332.28 | 221.15 | 158.97 | 327.27 | 246.54 | 217.31 | 85.15 | 279.88 | 356.07 | 260.28 | 199.28 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Receivables Turnover TTM | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | - | -0.00 | - | - | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | -83.16% | -59.94% | -36.54% | -30.89% | -11.28% | -29.82% | 209.23% | 121.53% | 0.43% | -5.61% | -65.49% | -50.27% | |||||
| EPS Growth (1Y) | -83.16% | -59.94% | -36.54% | -30.89% | -11.28% | -30.72% | 204.04% | 117.81% | -69.36% | -70.83% | -89.29% | -84.57% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -3.49 | -4.18 | -1.43 | -0.89 | -0.74 | -1.02 | -1.74 | -1.39 | -1.63 | -5.91 | -14.49 | -17.40 | |||||
| P/B TTM | -0.15 | -0.40 | -0.37 | -0.25 | -0.25 | -0.32 | -0.95 | -0.76 | -0.88 | -3.87 | -4.05 | -6.42 | |||||
| Market Cap | 238.57K | 584.50K | 506.97K | 316.11K | 298.22K | 357.86K | 972.18K | 709.75K | 745.54K | 2.94M | 2.62M | 4.02M | |||||
| Enterprise Value | 237.08K | 583.00K | 505.47K | 314.62K | 295.48K | 355.82K | 970.93K | 703.62K | 742.90K | 2.94M | 2.61M | 4.11M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -105.86K | -55.78K | -57.88K | -63.74K | -50.79K | -107.42K | -113.39K | -99.48K | -107.58K | -87.08K | -65.42K | -69.02K | |||||
| Net Debt | -1.49K | -1.50K | -1.49K | -1.49K | -2.74K | -2.04K | -1.25K | -6.13K | -2.64K | -1.69K | -1.77K | 97.15K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
GROOVE BOTANICALS INC. (GRVE) — SEC Financial Statements & Analysis
GROOVE BOTANICALS INC. (GRVE) is a crude petroleum & natural gas company, incorporated in CO. GROOVE BOTANICALS INC. trades on OTC as: GRVE. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), GROOVE BOTANICALS INC. reported a Debt-to-Equity ratio of -1.00x, a Price-to-Book (P/B) ratio of -0.15x (TTM), at a market cap of $238.57K. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.00x
- P/B TTM
- -0.15x
- Market Cap
- $238.57K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is GROOVE BOTANICALS INC. in?
GROOVE BOTANICALS INC. (GRVE) operates in the Crude Petroleum & Natural Gas industry.
What is GRVE's market cap?
GROOVE BOTANICALS INC. (GRVE) has a market capitalization of $238.57K as of 2026-06-30.
What exchange does GRVE trade on?
GROOVE BOTANICALS INC. (GRVE) trades on the OTC.
Where is GROOVE BOTANICALS INC. incorporated?
GROOVE BOTANICALS INC. is incorporated in CO.